Drugs / CHI-554
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04577612 | Sep 2020 → May 2021 | anxiety, panic disorder | Canopy Growth Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CHI-554 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04577612 ↗ |
| Known as | CBD | “This is a randomized, double-blind, placebo-controlled phase 2b clinical trial examining the effects of CHI-554 (CBD) on Fear (F-01)” NCT04577612 ↗ |